Abstract��OBJECTIVE To enhance the level of drug emergency inspection managements, and provide new ideas to deal with the drug incidents. METHODS Firstly, the management courses of our drug emergency inspection were sorted out. Secondly, the solution ideas to the typical drug emergency incidents were analyzed. Thirdly, the relational experiences of developed countries were researched. RESULTS The emergency management of our country had experienced from zero to full, and the responsible institution experienced from the point to surface. Although the emergency network had been basically established, each component was insufficient. We formulated a series of measures to strengthen the management with the analysis results on typical cases and the experiences of developed countries. CONCLUSION A special solution idea and four innovative measures were made by a combination of theory and practice. The firstly, a whole system management plan was drawn up which could form a system cohesion and reverse the individual combat. The secondly, the technical plan was proposed which could provide the reasonable path to find reason. The thirdly, three effective measures were designed which could provide supplementary resources for management plan and technical plan. The fourthly, the government and enterprises strategies were suggested which could prevent from the source. In brief, our emergency management ability would be significantly enhanced by implementing the mentioned measures.
��־��, ���. ҩƷӦ����������̽�����о�[J]. �й�ҩѧ��־, 2015, 50(14): 1255-1258.
GAO Zhi-feng, YANG Hua-xin. Innovative Thinking on the Management of Drug Emergency Inspection. Chinese Pharmaceutical Journal, 2015, 50(14): 1255-1258.
GAO Z F. Discussion on the reaction mechanism of drug incidents in China. Chin J Pharmcovig(�й�ҩ�ﾯ��),2013,10(4):207-209.
[2]
XIE Z J. Practice research on emergency testing investigation of the Armillarisin A Injection (I). Chin Pharm Aff(�й�ҩ��), 2009,23(3):243-245.
[3]
YU Y Y, FENG L, LIU J J. Analysison the globalmarkets of antitumordrugs. Chin Pharm J(�й�ҩѧ��־),2013,48(2):155-158.
[4]
XIE Z J. Research on Drug Emergency Inspection Cases(ҩƷ����Ӧ�����鰸���о�).Beijing: China Medical Science Press, 2012:44-49.
[5]
GAO Z F, LIN L, YANG H X. Research on the theoretical basis to the drug emergency inspection management . Chin J Pharmcovig(�й�ҩ�ﾯ��),2014,11(4):216-218.
[6]
XIE Z J. Research on Drug Emergency Inspection of Qieryao Event (���ҩͻ���¼�Ӧ�������о�).Beijing: China Medical Science Press, 2012:2-16.
[7]
ZENG Y B, YANG S M. The research analysis and enlightenment of fighting against counterfeit drugs in abroad . Chinese Journal Pharmaceutical Economics(�й�ҩ�ﾭ��ѧ),2007,2(5):643-644.
[8]
GAO Z F, YANG H X. Discussion on the process management of Drug emergency inspection. Chin Pharm J(�й�ҩѧ��־),2014,49(21):1957-1960.
[9]
GAO Z F, ZHANG Q M, YANG H X. Discussion on the management of pharmaceutical standards in NIFDC. Chin Pharm Aff(�й�ҩ��),2012,26(8):873-874. SUN Y Q. Discussion on the ADR countermeasures of traditional Chinese medicine. Chin J Hosp Pharm(�й�ҽԺҩѧ��־), 2006,26(6):781-782. WANG P, ZANG H C, ZENG Y Z. The causes and controlto the quality riskof pharmaceutical production process.Chin Pharm J(�й�ҩѧ��־),2011,46(13):969-972.
2015, Vol. 50 
